Gene · 7074
Papers2,121
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,121
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pals1 functions in redundancy with SMAP1 to inhibit Arf6 in order to prevent Rac1-dependent colorectal cancer cell migration and invasion. | Cancer Gene Ther | 2023 | 36494580 | PubTator, text mining | PubMed |
| Loss of cell-cell adhesion triggers cell migration through Rac1-dependent ROS generation. | Life Sci Alliance | 2023 | 36446524 | PubTator, text mining | PubMed |
| Flotillin-1 palmitoylation turnover by APT-1 and ZDHHC-19 promotes cervical cancer progression by suppressing IGF-1 receptor desensitization and proteostasis. | Cancer Gene Ther | 2023 | 36257975 | PubTator, text mining | PubMed |
| ALKBH5 inhibits thyroid cancer progression by promoting ferroptosis through TIAM1-Nrf2/HO-1 axis. | Mol Cell Biochem | 2023 | 36070054 | PubTator, text mining | PubMed |
| The role of prolactin/vasoinhibins in cardiovascular diseases. | Animal Model Exp Med | 2023 | 35923071 | PubTator, text mining | PubMed |
| Vitamin D receptor and STAT6 interactome governs oesophageal epithelial barrier responses to IL-13 signalling. | Gut | 2023 | 35918104 | PubTator, text mining | PubMed |
| Characterization of Novel Derivatives of MBQ-167, an inhibitor of the GTP-binding proteins Rac/Cdc42. | Cancer Res Commun | 2022 | 36861094 | PubTator, text mining | PubMed |
| A Double Jeopardy: Loss of FMRP Results in DSB and Down-regulated DNA Repair. | 21 Century Pathol | 2022 | 36688938 | PubTator, text mining | PubMed |
Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review. | Cancer Drug Resist | 2022 | 36627894 | PubTator, text mining | PubMed |
| Role of histone methyltransferase SETDB1 in regulation of tumourigenesis and immune response. | Front Pharmacol | 2022 | 36582533 | PubTator, text mining | PubMed |
| Recent Updates on the Role of the MicroRNA-10 Family in Gynecological Malignancies. | J Oncol | 2022 | 36578791 | PubTator, text mining | PubMed |
| Current Progress of EMT: A New Direction of Targeted Therapy for Colorectal Cancer with Invasion and Metastasis. | Biomolecules | 2022 | 36551152 | PubTator, text mining | PubMed |
| TIAM1-mediated synaptic plasticity underlies comorbid depression-like and ketamine antidepressant-like actions in chronic pain. | J Clin Invest | 2022 | 36519542 | PubTator, text mining | PubMed |
| Editor's Note: Balanced Tiam1-Rac1 and RhoA Drives Proliferation and Invasion of Pancreatic Cancer Cells. | Mol Cancer Res | 2022 | 36458417 | PubTator, text mining | PubMed |
| Investigation of Genetic Variants Associated with Tryptophan Metabolite Levels via Serotonin and Kynurenine Pathways in Patients with Bipolar Disorder. | Metabolites | 2022 | 36422266 | PubTator, text mining | PubMed |
| TIAM2 promotes proliferation and invasion of osteosarcoma cells by activating the JAK2/STAT3 signaling pathway. | J Bone Oncol | 2022 | 36419799 | PubTator, text mining | PubMed |
| Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation. | J Med Life | 2022 | 36415513 | PubTator, text mining | PubMed |
| Identification and validation of immune and prognosis-related genes in hepatocellular carcinoma: A review. | Medicine (Baltimore) | 2022 | 36401409 | PubTator, text mining | PubMed |
| Phosphatidylserine exposure modulates adhesion GPCR BAI1 (ADGRB1) signaling activity. | J Biol Chem | 2022 | 36370845 | PubTator, text mining | PubMed |
| The use of integrated text mining and protein-protein interaction approach to evaluate the effects of combined chemotherapeutic and chemopreventive agents in cancer therapy. | PLoS One | 2022 | 36367850 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7074/papers?page=10